The human papillomavirus (HPV) E6* proteins from high-risk, mucosal HPVs can direct degradation of cellular proteins in the absence of full-length E6 protein

Journal of Virology

Volumn 83, Issue 19, 2009, Pages 9863-9874

  Pim, David ^a   Tomaić, Vjekoslav ^a   Banks, Lawrence ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; PROTEASOME; PROTEIN DLG; PROTEIN E6; PROTEIN KINASE B; PROTEIN MAGI 1; PROTEIN MAGI 2; PROTEIN SCRIBBLE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 18; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN TARGETING; SIGNAL TRANSDUCTION;

BASE SEQUENCE; CELL LINE, TUMOR; DNA-BINDING PROTEINS; GENES, P53; HUMANS; MICROSCOPY, FLUORESCENCE; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; MUCOUS MEMBRANE; ONCOGENE PROTEINS, VIRAL; OPEN READING FRAMES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-AKT; RISK; SEQUENCE HOMOLOGY, NUCLEIC ACID;

HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

EID: 70349269128     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00539-09     Document Type: Article

References (35)

1. Chen, J. J., C. E. Reid, V. Band, and E. J. Androphy. 1995. Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein. Science 269:529-531.
2. Crook, T., and K. H. Vousden. 1992. Properties of p53 mutations detected in primary and secondary cervical cancers suggest mechanisms of metastasis and involvement of environmental carcinogens. EMBO J. 11:3935-3940.
3. Etscheid, B. G., S. A. Foster, and D. A. Galloway. 1994. The E6 protein of human papillomavirus type 16 functions as a transcriptional repressor in a mechanism independent of the tumor suppressor protein, p53. Virology 205:583-585.
4. Filippova, M., H. Song, J. L. Connolly, T. S. Dermody, and P. J. Duerksen- Hughes. 2002. The human papillomavirus 16 E6 protein binds to tumor necrosis factor (TNF) R1 and protects cells from TNF-induced apoptosis. J. Biol. Chem. 277:21730-21739.
5. Filippova, M., L. Parkhurst, and P. J. Duerksen-Hughes. 2004. The human papillomavirus 16 E6 protein binds to Fas-associated death domain and protects cells from Fas-triggered apoptosis. J. Biol. Chem. 279:25729-25744.
6. Filippova, M., M. M. Johnson, M. Bautista, V. Filippov, N. Fodor, S. S. Tungteakkhun, S., K. Williams, and P. J. Duerksen-Hughes. 2007. The large and small isoforms of human papillomavirus type 16 E6 bind to and differentially affect procaspase 8 stability and activity. J. Virol. 81:4116-4129. (Pubitemid 46586906)
7. Gardiol, D., C. Kühne, B. Glaunsinger, S. S. Lee, R. Javier, and L. Banks. 1999. Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation. Oncogene 18:5487-5496. (Pubitemid 29481495)
8. Gardiol, D., A. Zacchi, F. Petrera, G. Stanta, and L. Banks. 2006. Human discs large and scrib are localized at the same regions in colon mucosa and changes in their expression patterns are correlated with loss of tissue architecture during malignant progression. Int. J. Cancer 119:1285-1290. (Pubitemid 44258801)
9. Glaunsinger, B. A., S. S. Lee, M. Thomas, L. Banks, and R. Javier. 2000. Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins. Oncogene 19:5270-5280.
10. Graham, F. L., and A. J. van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456-467.
11. Guccione, E., D. Pim, and L. Banks. 2004. HPV-18 E6*I modulates HPV-18 full-length E6 functions in a cell cycle dependent manner. Int. J. Cancer 110:928-933. (Pubitemid 38758522)
12. Huibregtse, J. M., M. Scheffner, and P. M. Howley. 1991. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J. 10:4129-4135.
13. Huibregtse, J. M., M. Scheffner, and P. M. Howley. 1993. Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53. Mol. Cell. Biol. 13:775-784.
14. Humbert, P., S. Russell, and H. Richardson. 2003. Dlg, Scribble and Lgl in cell polarity, cell proliferation and cancer. Bioessays 25:542-553. (Pubitemid 36702323)
15. Mantovani, F., and L. Banks. 1999. Inhibition of E6 induced degradation of p53 is not sufficient for stabilization of p53 protein in cervical tumour derived cell lines. Oncogene 18:3309-3315. (Pubitemid 29286976)
16. Mantovani, F., and L. Banks. 2001. The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene 20:7874-7887. (Pubitemid 33135314)
17. Massimi, P., N. Narayan, A. Cuenda, and L. Banks. 2006. Phosphorylation of the discs large tumour suppressor protein controls its membrane localization and enhances its susceptibility to HPVE6-induced degradation. Oncogene 25:4276-4285. (Pubitemid 44100498)
18. Menges, C. W., L. A. Baglia, R. Lapoint, and D. J. McCance. 2006. Human papillomavirus type 16 E7 up-regulates AKT activity through the retinoblastoma protein. Cancer Res. 66:5555-5559.
19. Pim, D., A. Storey, M. Thomas, P. Massimi, and L. Banks. 1994. Mutational analysis of HPV-18 E6 identifies domains required for p53 degradation in vitro, abolition of p53 transactivation in vivo and immortalisation of primary BMK cells. Oncogene 9:1869-1876. (Pubitemid 24194152)
20. Pim, D., P. Massimi, S. M. Dilworth, and L. Banks. 2005. Activation of the protein kinase B pathway by the HPV-16 E7 oncoprotein occurs through a mechanism involving interaction with PP2A. Oncogene 24:7830-7838. (Pubitemid 41715189)
21. Pim, D., P. Massimi, and L. Banks. 1997. Alternatively spliced HPV-18E6* protein inhibits E6 mediated degradation of p53 and suppresses transformed cell growth. Oncogene 15:257-264. (Pubitemid 27370872)
22. Pim, D., and L. Banks. 1999. HPV-18E6* protein modulates the E6-directed degradation of p53 by binding to full-length HPV-18 E6. Oncogene 18:7403-7408. (Pubitemid 30035041)
23. Sabio, G., J. S. Arthur, Y. Kuma, M. Peggie, J. Carr, V. Murray-Tait, F. Centeno, M. Goedert, N. A. Morrice, and A. Cuenda. 2005. p38 gamma regulates the localisation of SAP97 in the cytoskeleton by modulating its interaction with GKAP. EMBO J. 24:1134-1145. (Pubitemid 40516597)
24. Sasaki, T., M. Kishi, M. Saito, T. Tanaka, N. Higuchi, E. Kominami, N. Katunuma, and T. Murachi. 1990. Inhibitory effect of di- and tripeptidyl aldehydes on calpains and cathepsins. J. Enzyme Inhib. 3:195-201. (Pubitemid 20080690)
25. Schneider-Gädicke, A., and E. Schwarz. 1986. Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes. EMBO J. 5:2285-2292.
26. Scheffner, M., T. Takahashi, J. M. Huibregtse, J. D. Minna, and P. M. Howley. 1992. Interaction of the human papillomavirus type 16 E6 oncoprotein with wild-type and mutant human p53 proteins. J. Virol. 66:5100-5105.
27. Smith, D. B., and K. S. Johnson. 1988. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67:31-40. (Pubitemid 18178778)
28. Smotkin, D., and F. O. Wettstein. 1986. Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein. Proc. Natl. Acad. Sci. USA 83:4680-4684.
29. Storrs, C., and S. Silverstein. 2007. PATJ, a tight junction-associated PDZ protein, is a novel degradation target of high-risk human papillomavirus E6 and the alternatively spliced isoform 18E6*. J. Virol. 8:4080-4090. (Pubitemid 46586903)
30. Tang, S., M. Tao, J. P. McCoy, Jr., and Z. M. Zheng. 2006. The E7 oncoprotein is translated from spliced E6*I transcripts in high-risk human papillomavirus type 16- or type 18-positive cervical cancer cell lines via translation reinitiation. J. Virol. 80:4249-4263.
31. Tao, M., M. Kruhlak, S. Xia, E. Androphy, and Z. M. Zheng. 2003. Signals that dictate nuclear localization of human papillomavirus type 16 oncoprotein E6 in living cells. J. Virol. 77:13232-13247. (Pubitemid 37494319)
32. Thomas, M., R. Laura, K. Hepner, E. Guccione, C. Sawyers, L. Lasky, and L. Banks. 2002. Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation. Oncogene 21:5088-5096. (Pubitemid 34907736)
33. Thomas, M., P. Massimi, C. Navarro, J. P. Borg, and L. Bank. 2005. The hScrib/Dlg apico-basal control complex is differentially targeted by HPV-16 and HPV-18 E6 proteins. Oncogene 24:6222-6230. (Pubitemid 43080045)
34. Tomaić, V., D. Gardiol, P. Massimi, M. Ozbun, M. Myers, and L. Banks. 2009. Human and primate tumour viruses use PDZ binding as an evolutionarily conserved mechanism of targeting cell polarity regulators. Oncogene 28:1-8.
35. Cip1. Mol. Cell. Biol. 22:7041-7052.